Drug Trial Radar · NCT07634484
A Post-Marketing Clinical Trial of Pemafibrate in Patients with Hypercholesterolemia and Inadequate Response to Statins
Last checked: Nov 20, 2026Latest source record: Jul 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
120
Planned (sponsor's estimate)
Start
Jul 1, 2026
Primary completion
Jul 31, 2027
Study completion Jul 31, 2027
Sponsor
- Lead sponsor
- Kowa Company, Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jun 8, 2026
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To investigate the efficacy and safety of Pemafibrate 0.2 mg/day or 0.4 mg/day for 12 weeks in patients with hypercholesterolemia and inadequate response to statins, using placebo as a control.
Conditions
- Hypercholesterolemia
Interventions
Pemafibrate 0.2 mg/dayDrug
Administered orally once daily
Pemafibrate 0.4 mg/dayDrug
Administered orally once daily
PlaceboDrug
Administered orally once daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage change from baseline in LDL-C (direct)Time frame: 4, 8, and 12 weeks after administration
Locations
10 sites in 1 country. Site status is shown where the registry gives one.
NTT Medical Center Sapporo
Hokkaido, Japan · Recruiting
Ami Higashi Clinic
Ibaraki, Japan · Recruiting
Olive Takamatsu Medical Clinic
Kagawa, Japan · Recruiting
Medical Corporation Shintokai Yokohama Minoru Clinic
Kanagawa, Japan · Recruiting
Medical Corporation Heishinkai OCROM Clinic
Osaka, Japan · Recruiting
Hirose Clinic
Saitama, Japan · Recruiting
Medical Corporation Yukeikai Asano Internal Medicine Clinic
Saitama, Japan · Recruiting
Medical Corporation Asbo Tokyo Asbo Clinic
Tokyo, Japan · Recruiting
Medical Corporation Heishinkai ToCROM Clinic
Tokyo, Japan · Recruiting
Shimokitazawa Tomo Clinic
Tokyo, Japan · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.